Circulating tumour DNA and molecular residual disease in oesophageal cancer: Clinical readiness, evidence gaps and trial-ready applications

Critical Reviews in Oncology/Hematology · Published 2026-07-27 · DOI 10.1016/j.critrevonc.2026.105504

Authors (5)

Yu-Qi Meng, Hai-Tian Li, Gengyuan Zhang, Jun-Ping Lin, Yi-Ming Hui

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Meng, Y., Li, H., Zhang, G., et al. (2026). Circulating tumour DNA and molecular residual disease in oesophageal cancer: Clinical readiness, evidence gaps and trial-ready applications. Critical Reviews in Oncology/Hematology. https://doi.org/10.1016/j.critrevonc.2026.105504

Related articles

• TROP-2 in solid tumors: From oncogenic driver to therapeutic target with antibody-drug conjugates · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Molecular mechanisms of targeted therapy in breast cancer: An integrated signaling network perspective · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• The adipose microenvironment in colorectal cancer: Navigating the nexus of inflammation, metabolism, and metastatic reprogramming · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Biomimetic nanoparticles for metastatic breast cancer: Advancing targeted drug delivery beyond conventional nanomedicine · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Remodeling the immune microenvironment: Engineering IL-2 variants to overcome clinical bottlenecks in PD-1 inhibitor plus chemotherapy · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Extracellular vesicle-mediated immunity-coagulation interaction in cancer-associated thrombosis during the immunotherapy era · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Revisiting Diffuse Gliomas in the Era of Precision Medicine: Molecular Insights and Therapeutic Implications · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Liquid biopsy for early cancer detection in hereditary cancer syndromes: Current evidence · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Current status and prospects of chemotherapy-free strategies in ovarian cancer · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Advances in the mechanisms of exosome-derived non-coding RNAs regulating T-cell infiltration in tumors · Critical Reviews in Oncology/Hematology · 2026 · Same journal